Mesenchymal stem cells to augment therapeutic angiogenesis in hind-limb ischemia models: How important is their source?

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Duffy, Garry P ^a   Herron, Caroline C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; CAPILLARY DENSITY; CRITICAL LIMB ISCHEMIA; ENDOTHELIUM; GASTROCNEMIUS MUSCLE; MESENCHYMAL STEM CELL; MORBIDITY; MORTALITY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE REGENERATION; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW; SMOOTH MUSCLE FIBER; ANIMAL; ENDOTHELIUM CELL; HINDLIMB; ISCHEMIA; MALE; METABOLISM; VASCULARIZATION;

ANIMALS; ENDOTHELIAL CELLS; HINDLIMB; ISCHEMIA; MALE;

EID: 84887880477     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt342     Document Type: Review

References (6)

1. A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia. da Cunha FF, Martins L, Martin PK, Stilhano RS, Han SW, Stem Cell Res Ther 2013 4 86 10.1186/scrt245 23890057
2. Collateral density, remodelling, and VEGF-A expression differ widely between mouse strains. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE, Physiol Genomics 2007 30 179 191 10.1152/physiolgenomics.00047.2007 17426116 (Pubitemid 47173281)
3. Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Limbourg A, Korff T, Napp LC, Schaper W, Drexler H, Limbourg FP, Nat Protoc 2009 4 1737 1746 10.1038/nprot.2009.185 19893509
4. Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia. Hastings CL, Kelly HM, Murphy MJ, Barry FP, O'Brien FJ, Duffy GP, J Control Release 2012 161 73 80 10.1016/j.jconrel.2012.04.033 22562065
5. Perivascular delivery of encapsulated mesenchymal stem cells improves postischemic angiogenesis via paracrine activation of VEGF-A. Katare R, Riu F, Rowlinson J, Lewis A, Holden R, Meloni M, Reni C, Wallrapp C, Emanueli C, Madeddu P, Arterioscler Thromb Vasc Biol 2013 33 1872 1880 10.1161/ATVBAHA.113. 301217 23766261
6. Embryonic stem cell-derived endothelial cells for treatment of hindlimb ischemia. Huang NF, Niiyama H, De A, Gambhir SS, Cooke JP, J Vis Exp 2009 23 ii.1034